Replies to post #427752 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

True, though this is not a substantial criticism and can easily be addressed by release of TLD and a journal article. Moreover, it’s not a highly negative criticism. They are not saying anything anyone who follows does not know already. I rather think they just want to associate their firm with the name in case it does well, and if it doesn’t they advised to hold, but not buy more. They put themselves smack dab in the middle while associating their firm with what they likely think will be a success or they’d not have advised to hold and a stock they claim to own.

I have seen these two doctors lurking around before, I just can’t place exactly where.

I have also said that a lot of the fairly smart but highly negative commentary for this stock, that people think they know “who”, I believe comes in fact from offshore in Asia. Multiple countries. So I am not surprised that these gentlemen follow as well. I have seen them lurking about NWBO before just need to recall where and in what context. Interestingly, there are multiple investment manager types lurking about this company from various countries in Asia, including India and Hong Kong.

[newman2021]

Poor Man, we might be too close to TLD/Pub, who knows what else and what not! Like Sojo says, I am hoping for the best while staying patience.

[dennisdave]

However, the one thing that these type of articles point out is the weakness in LP’s strategy to indefinitely withhold TLD because they need a Journal Article to fend off attacks against the results (and the company). Well, the longer they wait to release TLD, the more vulnerable the company becomes to negative sentiments, and likely from much more credible sources. The very thing that LP is trying to ostensibly prevent is exactly the kind of thing she’s creating.

what can I say 100% agree its getting absurd really